bibliographic entry 3654823 [be/3654823]
https://w3id.org/oc/corpus/be/3654823

is a

• bibliographic reference

content

• de Vos, S, Forero-Torres, A, Ansell, SM, Kahl, B, Cheson, BD, Bartlett, NL. A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. J Hematol Oncol (2014) 7: 44. DOI: 10.1186/1756-8722-7-44 PMID: 24919462

references

• https://w3id.org/oc/corpus/br/537082